Product Overview
[Drug Name]
Generic Name: Inosine Tablets
Trade Name: BiDi Inosine Tablets 0.2g x 100 Tablets
Pinyin Code: BiDi JiZuoPian
[Main Ingredients]
Each tablet contains 0.2g of the main ingredient, inosine. Excipients: lactose, sucrose, starch, sodium starch glycolate, and magnesium stearate.
[Properties]
This product is a white tablet.
[Indications/Main Functions]
For the adjunctive treatment of acute and chronic hepatitis.
[Specifications]
0.2g x 100 tablets (BiDi)
[Dosage and Administration]
Oral. Adults: 1-3 tablets at a time; children: 1 tablet at a time, 3 times daily.
[Adverse Reactions]
Occasionally, stomach discomfort may occur.
[Contraindications]
This product is contraindicated in patients with allergies.
[Drug Interactions]
Drug interactions may occur if used concurrently with other medications. Please consult your physician or pharmacist for details.
[Precautions]
1. This product is contraindicated in patients with allergies. 2. Consult your physician or pharmacist regarding dosage for children. 3. This product should only be used as an adjunctive treatment for liver disease after a physician has confirmed chronic hepatitis. 4. Liver function tests should be performed regularly. 5. In case of overdose or serious adverse reactions, seek medical attention immediately. 6. Do not use this product if its properties change. 7. Children must be supervised by an adult. 8. Keep this product out of reach of children.
[Pediatric Use]
This study has not been conducted and no reliable references are available.
[Elderly Use]
This study has not been conducted and no reliable references are available.
[Overdose]
Unknown.
[Pharmacology and Toxicology]
This product can directly penetrate the cell membrane and enter somatic cells, activating pyruvate oxidase, thereby enabling cells in a low-energy, hypoxic state to continue metabolism and participating in energy metabolism and protein synthesis.
